Skip to content
abecarnil

Structure via PubChem · Public domain (PubChem)

EntityQ4666461· pop 5· linked from 201 articles

Abecarnil (developmental code name ZK-112,119) is an anxiolytic drug from the β-carboline family. It is one of a relatively recently developed class of medicines known as the nonbenzodiazepines, which have similar effects to the older benzodiazepine group, but with quite different chemical structures. It is a partial agonist acting selectively at the benzodiazepine site of the GABAA receptor.

Chemical data

Formula
C24H24N2O4
Molecular weight
404.5 g/mol
IUPAC name
propan-2-yl 4-(methoxymethyl)-6-phenylmethoxy-9H-pyrido[3,4-b]indole-3-carboxylate
SMILES
CC(C)OC(=O)C1=NC=C2C(=C1COC)C3=C(N2)C=CC(=C3)OCC4=CC=CC=C4
InChIKey
RLFKILXOLJVUNF-UHFFFAOYSA-N
XLogP
4.4
Polar surface area
73.4 Ų
H-bond donors
1
H-bond acceptors
5
Formal charge
0

via PubChem

Drug data · ChEMBL

Max clinical phase
Phase 2
Molecule type
Small molecule

via ChEMBL · EBI

Wikidata facts

Mass
404.174
Show 4 more facts
World Health Organisation international non-proprietary name
阿贝卡尔
subject has role
anticonvulsant agent
chemical formula
C₂₄H₂₄N₂O₄
canonical SMILES
CC(C)OC(=O)C1=NC=C2C(=C1COC)C3=C(N2)C=CC(=C3)OCC4=CC=CC=C4
Sources (2)

via Wikidata · CC0

~2 min read

Encyclopedic overview

6 sections
Contents
  • Development
  • Pharmacology
  • Potential advantages
  • Photoswitchable analog
  • See also
  • References

Abecarnil (developmental code name ZK-112,119) is an anxiolytic drug from the β-carboline family. It is one of a relatively recently developed class of medicines known as the nonbenzodiazepines, which have similar effects to the older benzodiazepine group, but with quite different chemical structures. It is a partial agonist acting selectively at the benzodiazepine site of the GABAA receptor.

== Development == Abecarnil was originally developed as an anti-anxiety drug, but has not as yet been commercially developed for use in humans. It has mainly been used for research into the development of other new sedative and anxiolytic drugs. Investigations are continuing into its actions, and it is likely to be developed for use in the treatment of anxiety and as a less addictive substitute drug for the treatment of benzodiazepine and alcohol addiction.

Excerpted from Wikipedia’s “abecarnil” article, available under the CC BY-SA 4.0 licence.

Available in 5 languages

via Wikidata sitelinks · CC0